DexCom recently launched Dexcom Flex in Germany, a continuous glucose monitoring (CGM) system for Type 2 diabetes patients not on intensive insulin th...
Bullish
Alpha Wealth Funds, LLC, in its Q1 2026 investor letter, highlighted DexCom, Inc. (NASDAQ:DXCM) despite losing 7.14% in the quarter due to the War in ...
Bullish
DexCom (DXCM) has launched its new continuous glucose monitoring (CGM) system, Dexcom Flex, designed for adults with Type 2 diabetes who do not use in...
BofA Securities has lowered its price target for DexCom (NASDAQ:DXCM) shares from $100 to $80. The article mentions this change and provides market da...
Bullish
Dexcom has announced Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with Type 2 diabetes who do not use intensive i...
Bullish
DexCom's stock surged almost 7% after activist investor Elliott Investment Management took a major stake and reached a cooperation agreement with the ...
Bullish
DexCom outlined its long-term growth plan during its 2026 Investor Day, targeting over 10% annual revenue growth through 2030, along with margin expan...
DexCom, Inc. (NasdaqGS:DXCM) has announced a share repurchase program, committing to buy back up to $1,000 million worth of its shares. This program i...
Neutral
Benchmark reiterated a Buy rating and $77.00 price target on Dexcom (NASDAQ:DXCM) shares after the company's investor event. Dexcom outlined a new gro...
Bullish
Dexcom stock is reacting to its latest quarterly update and guidance, which highlighted double-digit revenue growth and increasing adoption of its G7 ...
Bullish
Benchmark has initiated coverage on DexCom Inc. (NASDAQ:DXCM) with a Buy rating and a $77 price target, anticipating margin expansion driven by the up...
Bullish
Dexcom Inc. reported strong Q1 2026 earnings, with EPS of $0.56 and sales of $1.2 billion, surpassing analyst estimates. This performance led to a sli...
DexCom, Inc. reported strong Q1 2026 results with sales of US$1.19 billion and net income of US$199.5 million, and reaffirmed its 2026 revenue outlook...
Bullish
DexCom (NASDAQ: DXCM) reported Q1 2026 revenue of $1.192 billion, a 15% year-over-year increase, driven by growth in both US and international markets...
Neutral
DexCom, Inc. (NASDAQ:DXCM) announced it will host an Investor Day on Thursday, May 14, 2026, from 1:15 PM to approximately 3:30 PM PDT. The event will...
Dexcom reported strong financial results for the first quarter of 2026, with revenue increasing 15% year-over-year to $1.192 billion. The company expa...
Bullish
DexCom's upcoming 15-day G7 continuous glucose monitoring (CGM) sensor is generating optimism ahead of its recent earnings release, reinforcing the co...